Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Notification

NICE recommends new psoriasis treatment

The National Institute for Health and Care Excellence has issued final draft guidance recommending a new treatment for psoriasis. Secukinumab (Cosentyx; Novartis) is recommended as an option for treating some adults with plaque psoriasis if they are unable to take standard systemic therapies and if the drug is provided with the agreed patient access scheme discount.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068636

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.